AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2021
May 25, 2021
32538_dirs_2021-05-25_501093ad-18a9-4b03-a86b-3d8ccb977749.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2021-05-21
Reporting Person: Sigal Charles Elliott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-21 | Common Stock | A | 3374 | $0.00 | Acquired | 3374 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-21 | Stock Option (Right to Buy) | $45.28 | A | 6748 | Acquired | 2031-05-20 | Common Stock (6748) | Direct |
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26